Technology | April 08, 2008

Mediware Medication Management Software Features Safety Upgrades

The newest version of Mediware's medication management software suite reportedly offers enhanced data integration and functional improvements for tracking of medication orders, administrations and histories.

Version 3.0 is said to provide functional improvements to each application in order to streamline communication between clinicians throughout the hospital. It also includes integration points designed to ease collaboration with other systems within the client�s environment.

Specific product enhancements for the suite include updated safe medication practices information to meet JCAHO inpatient safety standards, improved medication profiles and clinical information, increased alerts and notifications and upgraded screens and displays.

Mediware's suite combines the company's MediREC, WORx, MediMA and MediCOE applications. MediREC includes automated medication reconciliation that electronically captures home medications and provides longitudinal medication records to support reconciliation throughout a patient's stay. WORx is a pharmacy management solution for inpatient and outpatient settings, including inventory management, online adjudication and Web-based access for remote users. MediMAR includes bedside administration and documentation tools designed to ensure the correct medications are delivered to the right patient at the right time. MediCOE�s electronic clinician ordering streamlines orders associated with poor handwriting or patient misidentification.

April 2003


Additional Content

News | Pharmaceuticals

July 16, 2026 — Merck has received U.S. Food and Drug Administration (FDA) approval for Lipfendra (enlicitide) tablets ...

Home July 16, 2026
Home
News | Pharmaceuticals

Jan. 27, 2026 — Cytokinetics, Inc. has announced that Myqorzo (aficamten) is now available for prescription in 5 mg, 10 ...

Home January 28, 2026
Home
News | Pharmaceuticals

Nov. 19, 2025 — Promising results from a pivotal Phase 3 clinical trial of an investigational heart-attack drug were ...

Home November 19, 2025
Home
News | Pharmaceuticals

Sept. 25, 2025 — Kardigan has introduced the three late-stage clinical programs leading its robust pipeline, each ...

Home September 25, 2025
Home
News | Pharmaceuticals

Sept. 23, 2025 — CeleCor Therapeutics’ multinational Phase 3 clinical trial of its investigational heart-attack drug ...

Home September 23, 2025
Home
Subscribe Now